









Markets
/
Stocks
/
nasdaq-esla
/

Estrella Immunopharma Inc

ESLA

1.690USD

+0.110+6.96%

Close 12/19, 16:00（ET）Quotes delayed by 15 min

63.82MMarket Cap

LossP/E TTM



Estrella Immunopharma Inc

1.690

+0.110+6.96%

Overview Company Financials Analysis

Overview

Company

Financials

Analysis

Cash Flow Statement

You can access the annual and quarterly cash flow statements of Estrella Immunopharma Inc to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

Operating cash flows (indirect method)

Cash flow from continuing operating activities

82.82%-727.33K

96.32%-414.88K

-69.33%-465.98K

-574.10%-291.51K

-4914.13%-4.23M

-10313.48%-11.27M

74.99%-275.19K

---43.24K

---84.45K

---108.20K

---1.10M

Net income from continuing operations

-922.54%-4.80M

-443.28%-5.54M

-12.50%-2.10M

-44.65%-3.95M

82.87%-469.53K

62.97%-1.02M

35.17%-1.87M

---2.73M

---2.74M

---2.76M

---2.89M

Other non-cash items

----

-99.99%1.00

----

--5.49K

--8.98K

----

Change in working capital

202.37%3.85M

148.51%4.97M

269.21%1.48M

41.52%3.66M

-247.72%-3.77M

-503.91%-10.25M

-76.19%400.65K

--2.59M

--2.55M

--2.54M

--1.68M

-Change in prepaid expenses

93.35%-232.97K

236.72%358.86K

--201.07K

10539.26%3.62M

-6909.72%-3.50M

---262.48K

-100.00%0.00

--34.00K

---50.00K

--0.00

--833.33K

-Change in payables and accrued expense

80.60%-35.15K

99.00%-7.08K

-121.26%-83.92K

-36.49%42.41K

-581.06%-181.17K

-1373.93%-705.97K

497.68%394.77K

--66.78K

--37.66K

---47.90K

--66.05K

Cash from non-recurring investing activities

Cash from operating activities

82.82%-727.33K

96.32%-414.88K

-69.33%-465.98K

-574.10%-291.51K

-4914.13%-4.23M

-10313.48%-11.27M

74.99%-275.19K

---43.24K

---84.45K

---108.20K

---1.10M

Investing cash flow

Net cash flow from other investing activities

----

100.00%0.00

--5.07M

---112.30K

---136.53K

--0.00

Cash from non-current investing activities

Net cash flow from investing activities

----

100.00%0.00

--5.07M

---112.30K

---136.53K

--0.00

Financing cash flow

Cash flow from continuous financing activities

1333.60%1.04M

118.99%1.31M

-100.15%-29.46K

---270.35K

---84.09K

---6.90M

--20.05M

----

--0.00

Net cash flow from debt Issuance/repayment

----

--0.00

--300.00K

----

--0.00

Net cash flow from common stock issuance/repurchase

1348.65%1.05M

--1.35M

---29.46K

---270.35K

---84.09K

----

Net cash flow from preferred stock issuance/repurchase

----

--0.00

--9.02M

----

--0.00

Net cash flow from other financing activities

---12.65K

99.42%-40.00K

-100.00%0.00

--0.00

---6.90M

--10.73M

----

--0.00

Net cash from non-recurrent financing activities

Net cash from financing activities

1333.60%1.04M

118.99%1.31M

-100.15%-29.46K

---270.35K

---84.09K

---6.90M

--20.05M

----

--0.00

Net cash flow

Beginning cash balance

-85.45%1.32M

-98.10%421.47K

-63.01%916.92K

77.79%4.73M

214.11%9.05M

640.87%22.14M

-39.36%2.48M

--2.66M

--2.88M

--2.99M

--4.09M

Current period cash flow changes

107.18%310.02K

106.84%895.12K

-102.52%-495.44K

-212.53%-561.86K

-1854.29%-4.32M

-12000.24%-13.09M

1886.80%19.66M

---179.78K

---220.99K

---108.20K

---1.10M

Ending cash balance

-65.59%1.63M

-85.45%1.32M

-98.10%421.47K

68.02%4.17M

77.79%4.73M

214.11%9.05M

640.87%22.14M

--2.48M

--2.66M

--2.88M

--2.99M

Free cash flow

----

-705.79%-2.22M

-574.10%-291.51K

-4914.13%-4.23M

-10313.48%-11.27M

74.99%-275.19K

---43.24K

---84.45K

---108.20K

---1.10M

Currency unit

USD

Audit opinions

FAQs

What is the cash flow statement?



This report tracks the movement of cash into and out of the business, covering operating, investing, and financing activities. It highlights how well the company manages cash to support growth and meet its obligations.

KeyAI

